New research reported in Urology for November indicates that treatment with naftopidil, a long-acting alpha-1-blocker, can improve nocturia and other symptoms of benign prostatic hyperplasia (BPH) in patients unsuccessfully treated with tamsulosin. Reuters Health Information
This new study explores the issue of polypharmacy, with a focus on elderly patients being treated for chronic kidney disease. American Journal of Kidney Diseases
In a large prospective study, regular coffee drinking consumption was associated with lower rates of progression of advanced hepatitis C?related liver disease. Medscape Medical News
Review the features of these diseases and discuss the use of NSAIDs, DMARDs, and TNF-alpha antagonists in patients to help find the most successful treatments.
In this important paper on the treatment of cryptococcosis, several international experts have upgraded the 2000 recommendations. Faculty of 1000 Medicine